Recombinant Rotavirus C Non-structural protein 1

Shipped with Ice Packs
In Stock

Description

Genetic and Molecular Features

  • Gene localization: Encoded by genome segment 5, RVC NSP1 exhibits variability in its C-terminal domain, a trait conserved across rotavirus species .

  • Domain architecture:

    • N-terminal RING domain: Implicated in E3 ubiquitin ligase activity (putative) .

    • C-terminal domain: Variable region hypothesized to mediate host-specific interactions .

Table 1: Comparative Features of Rotavirus NSP1 Across Species

FeatureRotavirus A (RVA) NSP1Rotavirus C (RVC) NSP1 (Inferred)
Gene Segment55
Host Immune EvasionDegrades IRF3 Unknown (likely analogous)
Proteasomal DegradationYes (via IRF3 targeting) Not yet confirmed
Role in Viral SpreadPromotes cell-to-cell spread Uncharacterized

Functional Roles

  • Immune evasion: RVA NSP1 degrades IRF3 to block IFN production . While RVC NSP1’s role is unconfirmed, its structural similarities suggest analogous immune-subversion mechanisms .

  • Apoptosis modulation: RVA NSP1 activates PI3K/Akt and NF-κB pathways to suppress apoptosis . RVC NSP1 may share this function, but experimental validation is pending.

Recombinant Expression Systems

  • Yeast two-hybrid systems: Used to identify RVA NSP1-IRF3 interactions .

  • Transient transfection assays: Demonstrated RVA NSP1’s capacity to degrade IRF3 via proteasomes .

Table 2: Key Experimental Approaches for NSP1 Studies

MethodApplication in RVA NSP1 StudiesPotential for RVC NSP1
siRNA KnockdownConfirmed role in viral spread Untested
ImmunoprecipitationValidated NSP1-IRF3 interaction Requires RVC-specific antibodies
Luciferase ReporterMeasured IFN-β promoter suppression Applicable with RVC adaptations

Unresolved Questions

  • Host specificity: RVA NSP1 exhibits species-specific activity . Whether RVC NSP1 targets human or animal IRF3 homologs is unknown.

  • Structural stability: RVA NSP1 is stabilized by viral proteins/mRNAs late in infection . RVC NSP1’s turnover dynamics remain unstudied.

Challenges and Future Directions

The lack of direct studies on RVC NSP1 highlights critical gaps:

  1. Antibody development: Species-specific reagents are needed to detect RVC NSP1 in infected cells .

  2. Reverse genetics systems: Successful recovery of recombinant RVC encoding functional NSP1 is essential for mechanistic studies .

  3. Comparative virology: Parallel studies with RVA and RVC NSP1 could elucidate conserved vs. unique roles in immune evasion.

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but please specify any format requirements when ordering, and we will accommodate your request.
Lead Time
Delivery times vary depending on the purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. Request dry ice shipment in advance; additional fees apply.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Adding 5-50% glycerol (final concentration) and aliquoting is recommended for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form is generally stable for 6 months at -20°C/-80°C. Lyophilized form is generally stable for 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type will be determined during the manufacturing process. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Non-structural protein 1; NSP1; NCVP2; Non-structural RNA-binding protein 53; NS53
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-393
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Rotavirus C (strain RVC/Pig/United States/Cowden/1980) (RV-C)
Target Protein Sequence
MANSYREMLY WFGKTIDRNL PYVNTNGWRK QKGRKDGICL NCLDECKLYS CDHCGIKHKC GNCVLSECFL DVKNEFNKYR WLVFDEEPDQ AVLLQHWIMY KDYFLQKFNY RLATQAKILN MNKNQKFQLN EGRKRALSVP ITSQFLKFRL FGKIYIQFGT IMTNKIQPWL ELSTLKIGYL QLLNVERCSE LMATRGQFTT NVAKTACITE IKCRRPIYDN DCIIEAYLDK NDRGWKFAAI LGRRKIPVTQ KLAMEYFMKS LRAELFYYAH SRCHTLSNCP RWNEGLRLLN SSTLNIVFRR QFMNEIVEWF EIFSQYTGSH YEFITECVHD KSAITAFKQE IEDYIKEGKQ ITLKSVVPEE HAAYRHILRL RESLMLAIDA ALSRIRSQSM GVL
Uniprot No.

Target Background

Function
This protein inhibits host innate immunity by degrading host factors like IRF3, IRF5, and IRF7, which are essential for interferon production. It interacts with cullin RING ligases (CRLs), including CUL1 and CUL3, to modulate their ubiquitination activity.
Protein Families
Rotavirus NSP1 family
Subcellular Location
Host cytoplasm, host cytoskeleton.

Q&A

What is the genomic location and basic structure of rotavirus NSP1?

NSP1 is encoded by segment 5 of the double-stranded RNA genome in rotaviruses. It is approximately 55-kDa protein that accumulates in the cytoplasm of infected cells. The protein exhibits significant sequence variation among rotavirus strains, which may contribute to its strain-specific functions and host range restriction . While structural studies of other rotavirus non-structural proteins have been conducted using X-ray crystallography and cryo-electron microscopy, detailed structural analyses of NSP1 remain more limited compared to other rotaviral proteins .

How does NSP1 contribute to rotavirus pathogenesis?

NSP1 serves as a critical virulence determinant for rotavirus by antagonizing the host's innate immune response. It functions primarily by interacting with and promoting the proteasome-mediated degradation of interferon regulatory factors (IRFs), particularly IRF3, which is a key transcription factor necessary for interferon induction . Additionally, NSP1 has been shown to target other IRFs including IRF5, IRF7, and IRF9, thereby comprehensively suppressing the antiviral state establishment in infected cells . Experimental evidence from rotaviruses encoding C-truncated NSP1 demonstrates that while NSP1 is not essential for viral replication in certain permissive cell lines, it significantly enhances cell-to-cell spread of the virus and plays a substantial role in intestinal viral replication and pathogenesis in vivo .

How does NSP1 antagonize the host interferon response at the molecular level?

NSP1 employs a sophisticated mechanism to subvert the host's interferon (IFN) signaling pathway. Upon infection, rotavirus NSP1:

  • Directly interacts with IRF3 in the infected cell cytoplasm

  • Promotes rapid degradation of IRF3 through a proteasome-dependent pathway

  • Prevents IRF3 dimerization and nuclear translocation

  • Inhibits IFN promoter activity

This mechanism is evidenced by comparative studies between wild-type rotavirus and NSP1-deletion mutants. In cells infected with rotaviruses encoding wild-type NSP1, researchers observed rapid degradation of IRF3, severe decreases in IRF3 dimerization and nuclear translocation, and lack of IFN promoter activity. In contrast, when cells were infected with NSP1-deletion mutants, IRF3 underwent normal dimerization and nuclear translocation, resulting in stimulation of IFN promoter activity . This represents a unique viral strategy for immune evasion, as while several viruses can prevent IRF3 activation, rotavirus specifically accomplishes this by inducing IRF3 degradation.

Does NSP1 have functions beyond interferon antagonism?

Recent evidence suggests NSP1 possesses functions beyond interferon antagonism. Studies using NSP1-null rotaviruses in STAT1 knockout mice (which lack interferon signaling) revealed that the replication and pathogenesis defects of NSP1-null viruses were only minimally rescued in these animals . This finding indicates that NSP1 facilitates rotavirus replication in vivo through mechanisms that are largely independent of its interferon antagonism functions. The precise nature of these additional functions remains an active area of investigation, but they likely contribute to optimal viral replication in intestinal tissues, systemic spread to mesenteric lymph nodes, and efficiency of viral shedding and transmission .

How variable is NSP1 across different rotavirus strains and does this variability correlate with pathogenicity?

NSP1 exhibits significant sequence variation among rotavirus strains, more so than many other rotaviral proteins. This variability likely contributes to host range restriction and strain-specific pathogenicity profiles . Correlation studies between NSP1 sequence variations and virulence have shown connections between gene 5 (encoding NSP1) and virus virulence and spread. For example, research examining reassortants made from murine and rhesus rotaviruses demonstrated a strong correlation between gene 5 and virus virulence and spread capabilities . The molecular basis for how specific sequence variations in NSP1 affect host specificity and pathogenicity remains an important area for further research in understanding rotavirus strain-specific virulence.

What are the optimal methods for detecting NSP1 in clinical and research samples?

Multiple detection methods can be employed for NSP1 identification, each with varying sensitivity and applications:

MethodSensitivityApplicationsLimitations
Immunochromatography (ICT)ModerateRapid clinical screeningMay yield false positives
RT-qPCRHighPrecise detection and quantificationRequires specialized equipment
ELISAModerate-HighLaboratory diagnosisLess sensitive than molecular methods
Yeast two-hybrid systemN/AProtein interaction studiesNot for direct detection

Research has shown that immunochromatography assays may detect NSP1 in 100% of urine and stool samples from rotavirus-infected children, while RT-qPCR typically detects it in a smaller percentage (66.7% of urine and 50% of stool samples in one study) . The presence of NSP1 in urine samples also suggests potential extragastrointestinal spread of rotavirus infection, which has implications for understanding disease pathogenesis beyond the gastrointestinal tract . Selection of detection method should be based on the specific research question and required sensitivity.

What reverse genetics approaches are available for studying NSP1 function?

An optimized reverse genetics system has been successfully developed for generating recombinant murine rotaviruses with or without NSP1 expression . This approach involves:

  • Construction of plasmids containing rotavirus genome segments

  • Transfection of cells with these plasmids to recover infectious virus particles

  • Confirmation of genetic modifications via sequencing

  • Verification of NSP1 expression or absence via immunoblotting

This system allows for targeted manipulation of the NSP1 gene while maintaining the integrity of other viral genes, enabling precise investigation of NSP1's role in rotavirus biology. The reverse genetics approach has proven particularly valuable for studying NSP1 function in homologous animal models, where previously researchers were limited by the constraints of using heterologous simian rotaviruses in mouse models . This methodology represents a significant advancement that has enabled definitive characterization of NSP1's contribution to in vivo viral replication and pathogenesis.

What in vivo models are most appropriate for studying NSP1's role in pathogenesis?

The homologous murine rotavirus model in suckling mice represents the gold standard for studying NSP1's role in pathogenesis. This model offers several advantages:

  • Pathologically valid representation of rotavirus infection

  • Ability to study viral replication in relevant intestinal tissues

  • Capacity to assess diarrheal disease outcomes

  • Opportunity to investigate virus transmission among littermates

Studies using this model have revealed that NSP1-null murine rotaviruses display significantly reduced replication in the ileum, decreased systemic spread to mesenteric lymph nodes, diminished fecal shedding, lower diarrhea occurrence, and impaired transmission to uninoculated littermates . The defective replication of NSP1-null rotavirus in small intestinal tissues appears as early as one day post-infection, indicating NSP1's importance in the initial stages of viral pathogenesis. Both wild-type and knockout mice backgrounds (including 129sv, C57BL/6, and STAT1 knockout mice) have been used to dissect the interferon-dependent and independent functions of NSP1 .

How do 3' terminal consensus sequences affect NSP1 expression and rotavirus replication?

The 3' terminal sequences of rotavirus gene segments typically follow a consensus pattern that is important for genome replication and packaging. Interestingly, some rotavirus strains contain variations in these consensus sequences. For example, sequencing revealed that the 3' termini of segment 5 (encoding NSP1) in simian rotavirus SA11 variants and wild-type SA11 contained an atypical sequence (UGAACC) with an A insertion relative to the expected 3' consensus sequence (UGACC) .

Despite this deviation from the consensus, wild-type SA11 viruses were able to grow to high titer and produce NSP1, demonstrating that strict adherence to the 3' consensus sequence is not absolutely required for genome packaging, RNA replication, or viral gene expression . This finding has important implications for our understanding of the flexibility in rotavirus RNA recognition mechanisms and for the design of recombinant rotavirus systems. Researchers should consider this tolerance for sequence variation when constructing modified rotavirus genes for functional studies or vaccine development.

What molecular mechanisms explain NSP1's interferon-independent contribution to viral pathogenesis?

The discovery that NSP1-null rotavirus replication defects are only minimally rescued in STAT1 knockout mice (which lack interferon signaling) suggests that NSP1 contributes to viral pathogenesis through interferon-independent mechanisms . Several hypotheses have emerged to explain these additional functions:

  • NSP1 may interact with other cellular pathways beyond interferon signaling

  • The protein could contribute to efficient viral RNA replication or packaging

  • NSP1 might influence viral tropism in intestinal tissues

  • It could modulate cellular metabolism to favor viral replication

Methodological approaches to investigate these possibilities include:

  • Proteomics studies to identify NSP1 interaction partners beyond IRF proteins

  • Transcriptomics analyses of host cells infected with wild-type versus NSP1-null viruses

  • Comparative histopathology to assess differences in tissue tropism

  • Metabolic profiling of infected cells with and without NSP1 expression

Understanding these interferon-independent functions represents a frontier in rotavirus research that could reveal novel aspects of virus-host interactions and potentially identify new targets for antiviral intervention.

How do rotavirus strains with NSP1 modifications affect the microbiome and host inflammatory responses?

This question represents an emerging area of research that connects NSP1 function with broader host physiological responses. While direct evidence specific to NSP1's impact on microbiome composition is limited in the provided sources, methodological approaches to address this question would include:

  • Comparing gut microbiome composition in animals infected with wild-type versus NSP1-deficient rotaviruses using 16S rRNA sequencing

  • Measuring inflammatory cytokine profiles in intestinal tissues of infected animals

  • Assessing changes in gut barrier function and intestinal permeability

  • Investigating potential correlations between microbiome alterations and disease severity

This research direction could provide important insights into how viral proteins like NSP1 may influence disease outcomes not only through direct effects on host cells but also through indirect effects on the intestinal microenvironment. The relationship between viral infections, microbiome changes, and inflammatory responses represents a complex but potentially fruitful area for understanding rotavirus pathogenesis more comprehensively.

How can NSP1 modifications be leveraged for rotavirus vaccine development?

The identified role of NSP1 as a virulence determinant that can be manipulated without abolishing viral replication makes it an attractive target for rational vaccine design. NSP1-defective rotaviruses display several characteristics that could be advantageous in a vaccine candidate:

  • They maintain the ability to replicate but with significantly attenuated pathogenicity

  • They allow for robust immune recognition of viral antigens

  • They have reduced ability to antagonize host innate immune responses

  • They demonstrate diminished transmission, increasing vaccine safety

Researchers have proposed that "the generation of NSP1-defective human rotaviruses may be used to create a new class of more effective live rotavirus vaccines" . This approach aligns with strategies used for other RNA viruses, where deletion of genes encoding interferon antagonists has led to the development of attenuated vaccine candidates . Methodologically, reverse genetics systems now make it feasible to generate precisely engineered rotavirus strains with modified NSP1 genes that maintain immunogenicity while reducing virulence.

What is the current state of research on group C rotavirus NSP1 compared to group A?

The comparative analysis of NSP1 across different rotavirus groups represents an important research gap. Group C rotaviruses can cause gastroenteritis in humans, particularly in older children and adults, sometimes in outbreaks. Methodological approaches to address this research gap would include:

  • Comparative sequence analysis of NSP1 genes from group C versus group A rotaviruses

  • Functional studies examining the immune evasion capabilities of group C NSP1

  • Investigation of potential host range restriction factors associated with group C NSP1

  • Development of reverse genetics systems specific to group C rotaviruses

Understanding differences in NSP1 function across rotavirus groups could provide insights into group-specific pathogenicity and host range restrictions.

What technological advancements are needed to better understand NSP1 structure-function relationships?

Despite significant functional characterization, detailed structural information about NSP1 remains limited compared to other rotaviral proteins. Several technological advancements would accelerate progress in this area:

  • High-resolution structural determination techniques applied to NSP1:

    • X-ray crystallography of NSP1 alone and in complex with target proteins

    • Cryo-electron microscopy to visualize NSP1 in different functional states

    • NMR spectroscopy to understand dynamic aspects of NSP1 function

  • Advanced protein-protein interaction analyses:

    • Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces

    • Single-molecule FRET to study conformational changes during target binding

    • Computational modeling and simulation of NSP1-target interactions

  • Live-cell imaging approaches:

    • Super-resolution microscopy to visualize NSP1 localization during infection

    • Real-time tracking of NSP1-target interactions in living cells

    • Correlative light and electron microscopy to connect function with ultrastructure

These methodological advancements would help resolve outstanding questions about how NSP1's structure enables its multifunctional nature, including its ability to recognize and target multiple host proteins for degradation while potentially serving additional functions in viral replication and pathogenesis.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.